Top 5 Stocks to Buy Now
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
NASDAQ:ENGN

enGene Q4 2024 Earnings Report

enGene logo
$1.69 -0.03 (-1.74%)
Closing price 04:00 PM Eastern
Extended Trading
$1.68 0.00 (-0.30%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

enGene EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.40
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

enGene Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

enGene Announcement Details

Quarter
Q4 2024
Date
12/19/2024
Time
After Market Closes
Conference Call Date
Thursday, December 19, 2024
Conference Call Time
9:30AM ET

Conference Call Resources

Powered by Quartr

Earnings Documents

enGene's Q4 2024 Press ReleasePress Release
(8-K)
enGene's Q4 2024 Quarterly reportQuarterly report
(10-Q)
enGene's Q4 2024 Annual reportAnnual report
(10-K)

enGene Earnings Headlines

The V-8 engine isn’t going quietly—here’s every new car that still has one
 |  msn.comhttps://www.msn.com/en-us/autos/autos-luxury/the-v-8-engine-isn-t-going-quietly-here-s-every-new-car-that-still-has-one/ar-AA26i1L6
4 Common Problems With Inline-6 Engines
June 21 at 6:56 PM  |  msn.comhttps://www.msn.com/en-us/autos/general/4-common-problems-with-inline-6-engines/ar-AA26bG9g
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
June 22 at 1:00 AM  |  Porter & Company (Ad)
The Buick engine that created unexpected performance credibility
June 21 at 6:56 PM  |  msn.comhttps://www.msn.com/en-us/autos/news/the-buick-engine-that-created-unexpected-performance-credibility/ar-AA26bFu0
World’s first 100% hydrogen-fuelled marine engine delivering 2670kW power gets class approval
June 20 at 1:43 PM  |  msn.comhttps://www.msn.com/en-us/news/technology/world-s-first-100-hydrogen-fuelled-marine-engine-delivering-2670kw-power-gets-class-approval/ar-AA25Y80J
Why some diesel engines need wet cylinder sleeves, but they're rare in gas engines
June 20 at 1:43 PM  |  msn.comhttps://www.msn.com/en-us/autos/autos-trucks/why-some-diesel-engines-need-wet-cylinder-sleeves-but-they-re-rare-in-gas-engines/ar-AA266qvN
See More enGene Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like enGene? Sign up for Earnings360's daily newsletter to receive timely earnings updates on enGene and other key companies, straight to your email.

About enGene

enGene (NASDAQ:ENGN) is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs. enGene’s lead program is detalimogene voraplasmid (also known as detalimogene, and previously EG-70) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. Detalimogene was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA.

View enGene Profile
Earnings Tools